| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Access to hepatitis C care for people who inject drugs and people in prisons
|
Oru, Ena
|
|
2019
|
4 |
9 |
p. 662-663
|
artikel
|
| 2 |
Angioplasty with stenting for Budd-Chiari syndrome
|
Payancé, Audrey
|
|
2019
|
4 |
9 |
p. 657-659
|
artikel
|
| 3 |
Angioplasty with versus without routine stent placement for Budd-Chiari syndrome: a randomised controlled trial
|
Wang, Qiuhe
|
|
2019
|
4 |
9 |
p. 686-697
|
artikel
|
| 4 |
Boyce's sign in a large Zenker's diverticulum
|
Sharma, Suresh Chandra
|
|
2019
|
4 |
9 |
p. 742
|
artikel
|
| 5 |
Coeliac disease: a protracted course to diagnosis
|
W, Natalie
|
|
2019
|
4 |
9 |
p. 673-674
|
artikel
|
| 6 |
Controlling faecal incontinence in women by performing anal exercises with biofeedback or loperamide: a randomised clinical trial
|
Jelovsek, J Eric
|
|
2019
|
4 |
9 |
p. 698-710
|
artikel
|
| 7 |
Examining Britain's “drink problem”
|
Burki, Talha Khan
|
|
2019
|
4 |
9 |
p. 672-673
|
artikel
|
| 8 |
Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial
|
Aroniadis, Olga C
|
|
2019
|
4 |
9 |
p. 675-685
|
artikel
|
| 9 |
Faecal microbiota transplantation for IBS: still a long way to go
|
Moayyedi, Paul
|
|
2019
|
4 |
9 |
p. 656-657
|
artikel
|
| 10 |
Is there any alternative to science? Complementary and alternative therapies for inflammatory bowel diseases
|
Gomollón, Fernando
|
|
2019
|
4 |
9 |
p. 664-666
|
artikel
|
| 11 |
Management of metabolic syndrome and cardiovascular risk after liver transplantation
|
Fatourou, Evangelia M
|
|
2019
|
4 |
9 |
p. 731-741
|
artikel
|
| 12 |
Management of patients with hepatocellular carcinoma and portal vein tumour thrombosis: comparing east and west
|
Lu, Jian
|
|
2019
|
4 |
9 |
p. 721-730
|
artikel
|
| 13 |
Quality evidence on interventions for faecal incontinence
|
Knowles, Charles H
|
|
2019
|
4 |
9 |
p. 659-660
|
artikel
|
| 14 |
Research in brief
|
Baker, Holly
|
|
2019
|
4 |
9 |
p. 669
|
artikel
|
| 15 |
Safety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 study
|
Lowery, Maeve A
|
|
2019
|
4 |
9 |
p. 711-720
|
artikel
|
| 16 |
Targeted therapy for cholangiocarcinoma
|
Valle, Juan W
|
|
2019
|
4 |
9 |
p. 661-662
|
artikel
|
| 17 |
The challenge of inflammatory bowel disease in India
|
Furlow, Bryant
|
|
2019
|
4 |
9 |
p. 670-671
|
artikel
|
| 18 |
The Chills: The Triumph and Tragedy of Martin Phillipps
|
Higgs, Victoria
|
|
2019
|
4 |
9 |
p. 671-672
|
artikel
|
| 19 |
The great obesity debate: divided we fall
|
The Lancet Gastroenterology & Hepatology,
|
|
2019
|
4 |
9 |
p. 655
|
artikel
|
| 20 |
The harms of early cessation of trials on systematic reviews
|
Fairfield, Cameron J
|
|
2019
|
4 |
9 |
p. 667
|
artikel
|
| 21 |
The harms of early cessation of trials on systematic reviews – Authors' reply
|
Dijkgraaf, Marcel G
|
|
2019
|
4 |
9 |
p. 667-668
|
artikel
|
| 22 |
The Hep B Calculator: an online tool for cost-effectiveness analyses of treatment
|
Toy, Mehlika
|
|
2019
|
4 |
9 |
p. 668
|
artikel
|
Tijdschrift beschrijving